- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05615259
Comparison Between Exactech Guided Personalized Surgery (GPS) and Conventional Instrumentation of Shoulder Arthroplasty
February 23, 2024 updated by: Exactech
A Prospective, Multi-Center, Randomized Clinical Study of Total Shoulder Arthroplasty Comparing Exactech Guided Personalized Surgery (GPS) vs. Conventional Instrumentation
The primary objective of this study is to examine the optimization of Reverse Shouder Arthroplasty implant position between GPS and conventional techniques.
The secondary objective is to assess the effect of implant position using GPS vs. conventional techniques on ROM and patient reported outcomes.
Long-term follow-up to 10 years with minimum 2 year follow-up for patients.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
260
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sandrine Angibaud
- Phone Number: 352-377-1140
- Email: sandrine.angibaud@exac.com
Study Contact Backup
- Name: Rachael Craig
- Phone Number: 352-377-1140
- Email: rachael.craig@exac.com
Study Locations
-
-
New York
-
New York, New York, United States, 10021
- Recruiting
- Hospital for Special Surgery (HSS)
-
Contact:
- Phone Number: 845-608-2592
-
-
Virginia
-
Charlottesville, Virginia, United States, 22903
- Recruiting
- University of Virginia
-
Contact:
- Kaitlyn Shank
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients who meet eligibility criteria - Patients who consent to participate to return for follow-up visits out to 10 years
Description
Inclusion Criteria:
- Patient is at least 21 years of age at the time of surgery
- Patient is indicated for reverse shoulder arthroplasty
- Patient is willing to participate by complying with pre- and postoperative visit requirements
- Patient is willing to participate for the entire length of the prescribed follow-up (minimum 2 years)
- Patient is willing and able to review and sign a study informed consent form
- Preop CT scan is within 3 months of the date of surgery
Exclusion Criteria:
- Revision shoulder arthroplasty
- Reverse shoulder arthroplasty for fracture
- Need for structural glenoid bone graft
- Osteomyelitis of the proximal humerus or scapula; if a systemic infection or a secondary remote infection is suspected or confirmed, implantation should be delayed until infection is resolved
- Inadequate or malformed bone that precludes adequate support or fixation of the prosthesis
- Neuromuscular disorders that do not allow control of the joint
- Significant injury to the brachial plexus
- Non-functional deltoid muscles
- The patient is unwilling or unable to comply with the post-operative care instructions
- Patients who are a known drug or alcohol abuser, or have a psychological disorder (e.g. schizophrenia major depression, bipolar disorder, etc.) as defined by the DSM4 that affect follow-up care or treatment outcomes.
- Alcohol, drug, or other subtance abuse
- Any disease state that could adversaly affect the function or longevity of the implant
- Patient is pregnant
- Patient is a prisoner
- Patient who are currently involved in any personal injury litigation, medical-legal or worker's compensation claims
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Constant
Time Frame: Through study completion, an average of 1 per year
|
Constant Shoulder Score - 100 points scale about pain, Activities of daily living, Strength test, and Range of Motions questions about shoulder where 100 % corresponds to the highest pain
|
Through study completion, an average of 1 per year
|
ASES
Time Frame: Through study completion, an average of 1 per year
|
American Shoulder and Elbow Surgeons Score (ASES) - 100 points scale about shoulder pain and performance evaluation in activities of daily living where 100 indicates the best shoulder condition
|
Through study completion, an average of 1 per year
|
SST-12
Time Frame: Through study completion, an average of 1 per year
|
Shoulder Simple Test (SST) - 12 questions with yes/no responses that measure shoulder pain and function from a patient's perspective - 12 yes corresponds to 100%
|
Through study completion, an average of 1 per year
|
SPADI
Time Frame: Through study completion, an average of 1 per year
|
Shoulder Pain and Disability Index (SPADI) -13 questions assessing about pain scale (5 questions) and disability scale (8 questions) where 0 indicates no pain/no difficulty and 10 indicates worst pain imaginable/so difficult it requires help while performin these activities
|
Through study completion, an average of 1 per year
|
UCLA
Time Frame: Through study completion, an average of 1 per year
|
University of California Los Angeles Shoulder Score (UCLA) - 5 Items score which combines both physician (3 items) and patient assessment (2 items) whith a total range from 0-35 where 0 indicates worse shoulder function and 35 better shoulder function outcomes
|
Through study completion, an average of 1 per year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lawrence Gulotta, MD, Hospital for Special Surgery, New York
- Principal Investigator: Brian Werner, MD, University of Virginia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 23, 2020
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
September 30, 2031
Study Registration Dates
First Submitted
November 7, 2022
First Submitted That Met QC Criteria
November 7, 2022
First Posted (Actual)
November 14, 2022
Study Record Updates
Last Update Posted (Estimated)
February 26, 2024
Last Update Submitted That Met QC Criteria
February 23, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- CR18-004
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Technology
-
The University of Hong KongHaven of Hope Hospital; The Social Innovation and Entrepreneurship Development...Completed
-
The University of Hong KongHaven of Hope Hospital; The Social Innovation and Entrepreneurship Development...Completed
-
The University of Hong KongHaven of Hope Hospital; The Social Innovation and Entrepreneurship Development...CompletedTechnologyHong Kong
-
The University of Hong KongHaven of Hope Hospital; The Social Innovation and Entrepreneurship Development...CompletedTechnologyHong Kong
-
Erasme University HospitalCompleted
-
Yale UniversityNot yet recruiting
-
University of BrasiliaNot yet recruiting
-
The University of Hong KongGerontechnology Platform, The Social Innovation and Entrepreneurship Development...Not yet recruiting
-
The University of Hong KongHaven of Hope Hospital; The Social Innovation and Entrepreneurship Development...Completed
-
Erasme University HospitalCompleted